DTC
TARS icon

Deep Track Capital’s Tarsus Pharmaceuticals TARS Stock Holding History

Deep Track Capital’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231M Buy
3,666,768
+66,768
+2% +$4.27M 3.36% 7
2026
Q1 		$253M Buy
3,600,000
+595,966
+20% +$41.6M 4.12% 4
2025
Q4 		$246M Buy
3,004,034
+4,034
+0.1% +$301K 4.39% 5
2025
Q3 		$178M Buy
3,000,000
+1,250,000
+71% +$61.5M 4.98% 6
2025
Q2 		$70.9M Buy
1,750,000
+265,734
+18% +$12M 2.27% 15
2025
Q1 		$76.2M Buy
+1,484,266
New +$73.4M 2.47% 12

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Deep Track Capital's TARS Position: Q2 2026 in Review

Deep Track Capital increased its Tarsus Pharmaceuticals (TARS) stake by 1.9% in Q2 2026, buying an estimated $4.27M and bringing the position to 3,666,768 shares worth $231M. The position accounts for 3.36% of the portfolio, ranked #7.

Deep Track Capital first reported a position in TARS in Q1 2025 and has held it in 6 quarters since. The position peaked at $253M in Q1 2026. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Deep Track Capital held 3,666,768 shares of Tarsus Pharmaceuticals worth $231M as of Q2 2026.
  • Deep Track Capital bought 66,768 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $4.27M.
  • Tarsus Pharmaceuticals made up 3.36% of Deep Track Capital's portfolio in Q2 2026, its #7 holding.
  • Deep Track Capital first reported a position in Tarsus Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Deep Track Capital's Tarsus Pharmaceuticals position peaked at $253M in Q1 2026.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.